Dudley Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ECSS
ATO
Dudley Capital Management's ABBV Position: Q2 2026 in Review
Dudley Capital Management increased its AbbVie (ABBV) stake by 0.12% in Q2 2026, buying an estimated $5.59K and bringing the position to 22,307 shares worth $5.61M. The position accounts for 2.24% of the portfolio, ranked #11.
Dudley Capital Management first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Dudley Capital Management held 22,307 shares of AbbVie worth $5.61M as of Q2 2026.
- Dudley Capital Management bought 26 AbbVie shares in Q2 2026, an estimated $5.59K.
- AbbVie made up 2.24% of Dudley Capital Management's portfolio in Q2 2026, its #11 holding.
- Dudley Capital Management first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Dudley Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.